Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6G8X

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeROTATING ANODE
Source detailsRIGAKU FR-E SUPERBRIGHT
Temperature [K]100
Detector technologyCCD
Collection date2013-02-20
DetectorRIGAKU SATURN 944
Wavelength(s)1.54187
Spacegroup nameP 1 21 1
Unit cell lengths48.823, 70.741, 60.590
Unit cell angles90.00, 109.69, 90.00
Refinement procedure
Resolution44.410 - 1.760
R-factor0.167
Rwork0.165
R-free0.21700
Structure solution methodFOURIER SYNTHESIS
RMSD bond length0.013
RMSD bond angle1.110
Data reduction softwareXDS
Data scaling softwareSCALA
Phasing softwareBUSTER
Refinement softwareBUSTER (2.11.7)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]57.0481.770
High resolution limit [Å]1.7601.760
Rmeas0.0220.863
Number of reflections38613181
<I/σ(I)>24.94
Completeness [%]85.832.7
Redundancy1.9
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP7.22930.1M HEPES/NaOHpH=7.2, 34.0%w/v MPEG 2000, 0.02M Mercaptoethanol, 0.2M (NH4)2SO4

223532

PDB entries from 2024-08-07

PDB statisticsPDBj update infoContact PDBjnumon